These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Paraneoplastic Anti-3-hydroxy-3-methylglutary-coenzyme A Reductase Antibody-positive Immune-mediated Necrotizing Myopathy in a Patient with Uterine Cancer. Mizuma A, Kouchi M, Netsu S, Yutani S, Kitao R, Suzuki S, Murata K, Nagata E, Takizawa S. Intern Med; 2017; 56(14):1915-1918. PubMed ID: 28717093 [Abstract] [Full Text] [Related]
4. Anti-SRP immune-mediated necrotizing myopathy responsive to ofatumumab: a case report. Chen S, Yang J, He D, Fu J, Lai X, Zhao B, Chen X, Shang H. Front Immunol; 2023; 14():1301109. PubMed ID: 38169756 [Abstract] [Full Text] [Related]
8. [A case of amyloid myopathy diagnosed during the treatment of myopathy associated with anti-signal recognition particle antibodies]. Kawakami N, Katsuyama Y, Hagiwara Y, Yoshida H, Kim K, Harada K. Rinsho Shinkeigaku; 2017 Apr 28; 57(4):168-173. PubMed ID: 28367947 [Abstract] [Full Text] [Related]
15. Immune-mediated necrotizing myopathy which showed deposition of C5b-9 in the necrotic muscle fibers and was successfully treated with intensive combined therapy with high-dose glucocorticoids, tacrolimus, and intravenous immunoglobulins. Shimada T, Higashida-Konishi M, Akiyama M, Hama S, Izumi K, Matsubara S, Oshima H, Okano Y. Immunol Med; 2022 Sep 28; 45(3):175-179. PubMed ID: 35389818 [Abstract] [Full Text] [Related]
20. Hypothyroidism combined with anti-signal recognition particle immune-mediated necrotizing myopathy: A case report and review of the literature. Shi J, Meng H, Zhang W, Guo J. Clin Neuropathol; 2022 Nov 01; 41(2):83-88. PubMed ID: 35034689 [Abstract] [Full Text] [Related] Page: [Next] [New Search]